A-ZYME
LIVE

Serial Number

79219624

Owner

Ultraceuticals Pty Ltd

Attorney

Timothy J. Kelly

Filing Date

Sep 7, 2017

Add to watchlist:

No watchlists yet
View on USPTO

A-ZYME Trademark

Serial Number: 79219624 • Registration: 5537838

A-ZYME is a trademark filed by Ultraceuticals Pty Ltd on September 7, 2017. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Ultraceuticals Pty Ltd (9 trademarks)

Gladesville Business Park,

Entity Type: 98

Ultraceuticals Pty Limited (10 trademarks)

Suite 2 Level 4,

Entity Type: 82

Trademark Details

Filing Date

September 7, 2017

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Goods & Services

Anti-ageing creams, not medicated; anti-wrinkle cream; [ barrier creams for the skin; non-medicated barrier preparations for the skin; ] beauty care preparations, namely, [ skin moisturizing preparations and ] anti-wrinkle preparations; beauty preparations, namely, cosmetic preparations for skin renewal; [ non-medicated body care preparations, namely, body balm; ] coloring preparations for cosmetic purposes, namely, skin brightening and skin lightening preparations; conditioning preparations for the skin, namely, [ moisturizer and ] anti-wrinkle creams; cosmetic creams for toning the skin; [ Cosmetic creams and lotions for the care of the skin; cosmetics; cosmetics for the treatment of dry skin; cosmetics to remove pigmentation marks; ] exfoliate creams for the care of the skin; cosmetic moisturizing preparations for the skin; [ non-medicated lotions for skin care; non-medicated protective creams for the skin; ] cosmetic preparations for skin care; non-medicated preparations for the skin, namely, balms, creams and lotions [ ; cosmetic skincare preparations; cosmetic skin lightening compositions ]

Pharmaceutical preparations for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of dermatological disorders; [ sanitary preparations for medical purposes; Vitamin preparations in the nature of food supplements; ] Medicated skin care preparations; Ointments for pharmaceutical purposes for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such; medicated skin serums; pharmaceutical preparations in the nature of compounds having an anti-inflammatory activity; Medicated creams for the skin; Medicated creams for the face; [ Medicated preparations in the nature of balms and lotions for the regeneration of the skin; ] medicated preparations for the treatment of the skin; medicated preparations for use on the skin for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; medicated preparations in the form of ointments for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; Medicinal substances, namely, pharmaceutical preparations for use on the skin for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; [ moisturizing pharmaceutical preparations for use on the skin for use on the skin for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; ] pharmaceutical creams for use on the skin for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; preparations for the face for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; topical dermatological preparations for medical purposes for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions; topical pharmaceutical compositions for use on the skin for the prevention and treatment of dermatological ailments, namely, dry skin, scarred skin, sun-damaged skin, excess pigmentation, skin redness to achieve an improvement in such conditions

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Dec 23, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 23, 2025 XXCR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 5, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 5, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Nov 5, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 7, 2024 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 15, 2024 ADCH
TEAS SECTION 71 RECEIVED
Feb 19, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 14, 2023 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 13, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 13, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2022 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 5, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 14, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Jun 2, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 16, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 25, 2018 TCCA
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 16, 2018 GPRN
PRIORITY ACTION E-MAILED
Mar 16, 2018 GPRA
PRIORITY ACTION WRITTEN
Mar 16, 2018 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2018 CRFA
ASSIGNED TO LIE
Feb 19, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2018 TROA
REFUSAL PROCESSED BY IB
Jan 27, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 11, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jan 11, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2017 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 15, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 15, 2017 REAP
APPLICATION FILING RECEIPT MAILED
Nov 3, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2017 REPR